SOURCE: Micro Imaging Technology, Inc.

Micro Imaging Technology, Inc.

November 08, 2011 08:00 ET

Micro Imaging Technology Updates the Status of the MIT 1000A Accompanying Family of Bacteria Identifying Software

SAN CLEMENTE, CA--(Marketwire - Nov 8, 2011) - Micro Imaging Technology, Inc. (OTCBB: MMTC) (OTCQB: MMTC) today provided an update on the family of bacteria identifying software that accompanies the MIT 1000A. The System, manufactured exclusively for MIT by Hawthorne, CA-based OSI Optoelectronics, Inc., is a stand-alone optically-based bacteria identification system that uses proven principles of physics in conjunction with proprietary PC-based software and is USB compliant. The MIT 1000A can complete an identifying test in less than five (5) minutes and with a material cost of pennies -- adding further credence to MIT's claims of being able to annually save thousands of lives and tens of millions of dollars in health care costs with their unique technologies.

As explained by MIT's Chief Scientist, David Haavig, PhD: "In the US, around 76 million cases of food borne illnesses, resulting in 325,000 hospitalizations and 5,000 deaths, are estimated to occur each year. The leading cause of these illnesses and deaths are three main strains of bacteria: E. coli, Salmonella, and Listeria. Rapid identification of these disease causing pathogens in food is critical to the health and safety of all consumers."

Dr. Haavig further explained: "The AOAC Research Institute (AOAC RI) awarded the Company, in June 2009, Performance Tested MethodsSM (PTM) certification for the rapid identification of Listeria. The AOAC RI provides an independent third-party evaluation of methods and will award PTM certification to methods that demonstrate performance levels equivalent or better than other bacteria identifying methods. The MIT System underwent hundreds of individual tests over an eighteen-month period to earn AOAC RI's certification for the identification of Listeria; including evaluations of hardware, software, ease of use, documentation, ruggedness and accuracy."

Michael Brennan, MIT's Chairman, expanded on the Certification status: "MIT will begin the process of earning Performance Tested Methods Certification from the AOAC RI for the identification of E. coli and Salmonella in December, 2011. This certification process is far less difficult than the original Listeria certification. All hardware, software, documentation, and test procedures are identical to the Listeria certification process. The only items to prepare are the E. coli and Salmonella Identifiers, or database component, that should be concluded by early December."

About Micro Imaging Technology:

MIT is a California-based public company that has developed and patented a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process. The System identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any other conventional method. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current annual growth rate of 6.6 percent.

The thoroughly green MIT System can currently identify over twenty different species of bacteria without the use of chemicals, reagents, dyes or DNA processing. The only additive is clean water and a sample of the unknown bacteria. In addition to bacteria other microbes can be easily added to the System's identifying capabilities, including: protozoa, fungi, yeast and mold.

MIT, as mentioned in the foregoing, previously completed an extensive evaluation by the AOAC RI which included rigorous independent testing and thorough reviews by its expert examiners, including the U.S. Department of Agriculture. This evaluation process resulted in MIT being awarded the prestigious AOAC RI Certificate of Performance Testing (Certificate No. 060901). The AOAC RI Report is available from the Company. www.aoac.org

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the U.S. Securities and Exchange Commission, reference MMTC: www.sec.gov.

Contact Information